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Background/aim: The aim of this prospective study was to determine whether the preoperative oral intake of carbohydrate-rich drinks
by patients undergoing a coronary artery bypass graft attenuates postoperative insulin requirements, improves postoperative patient
discomfort, provides inotropic support, shortens the length of the ICU stay, and shortens the duration of postoperative mechanical
ventilation.
Materials and methods: This randomized prospective clinical study included 152 patients with coronary artery disease who were
divided into 4 groups. Carbohydrates were administered to 3 groups at different hours and doses before operation. The fourth group had
an 8-h preoperative fasting period. The inotropic and vasopressor requirements, ventilation time, and ICU stay time were recorded for
all of the groups. Patient wellbeing, mouth dryness, hunger, anxiety, and nausea were assessed using VAS scores of 1–10.
Results: Mouth dryness and hunger were significantly higher in the control group (P = 0.03, P = 0.02). The increase in blood glucose
level was significantly higher in the control group (P = 0.04). The exogenous insulin requirement was significantly higher in the control
group than in the other groups (P = 0.04).
Conclusion: The administration of carbohydrates before elective cardiac surgery reduced insulin resistance. Based on the VAS scores,
the intake of carbohydrates reduced mouth dryness and hunger. Overall, preoperative oral carbohydrate treatments can improve the
postoperative outcomes of coronary artery bypass graft surgeries.
Key words: Coronary artery bypass graft, carbohydrate, wellbeing, mouth dryness, hunger, anxiety, nausea

1. Introduction
The exposure of the human body to surgical or other
types of trauma creates a neurohumoral response in the
body, activating catabolic processes (1). Postoperative
insulin resistance is a characteristic feature of the catabolic
response to surgical injury (2). Moreover, a more complex
or lengthy surgery with regard to severity, tissue trauma,
and/or blood loss leads to a more severe development
of insulin resistance (3). An association with stress
hyperglycemia is commonly observed, especially in
critical illness, and can lead to an increase in postoperative
complications (4).
In cardiopulmonary bypass (CPB)-guided cardiac
surgery, the commonly associated systemic inflammatory
response syndrome can lead to marked antiinsulinergic
metabolic disorders and can be a major cause of
peripheral insulin resistance (5). However, preoperative
IV glucose treatments have been shown to benefit
* Correspondence: dromersavluk@hotmail.com

cardiac surgery patients. They have been associated with
reduced postoperative impairment to the cardiac muscle,
as suggested by a cardiac enzyme decrease, and fewer
complications, such as serious arrhythmias, the need for
vasopressor and inotropic agents, the duration of ventilator
support required, and the length of stay in the intensive
care unit (ICU) (6,7). Given that IV glucose infusions are
costly, invasive, and labor-intensive, an oral carbohydrate
drink was developed to provide a more efficient method
of delivering this carbohydrate load (8). In patients
undergoing surgery, the intake of oral carbohydrates the
night before surgery or 2 h before anesthesia was found
to decrease postoperative insulin resistance, with a slight
decrease in insulin-stimulated glucose disposal (9). The
intake of carbohydrates also decreases preoperative
discomfort (thirst, hunger, and anxiety) (10) and
postoperative discomfort, as demonstrated in colorectal
patients, in addition to decreasing the length of the
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postoperative hospital stay (11). However, some studies
have shown that the preoperative intake of carbohydrates
did not decrease the length of the hospital stay or improve
insulin resistance (12). Therefore, it remains unclear
whether preoperative intake of carbohydrates is beneficial
to patients.
The aim of this prospective study was to determine
whether the preoperative oral intake of carbohydraterich drinks in patients undergoing a coronary artery
bypass graft (CABG) attenuates postoperative insulin
requirements, improves postoperative patient discomfort,
provides inotropic support, shortens the length of the
ICU stay, and shortens the duration of postoperative
mechanical ventilation.
2. Materials and methods
This randomized prospective clinical study included 152
patients with coronary artery disease who were divided
into 4 groups. The study protocol was approved by the
regional ethics committee. The exclusion criteria consisted
of the following: steroid treatment, American Society of
Anesthesiologists (ASA) status of >IV, nonelective or
emergent surgery, reoperations, impaired gastrointestinal
motility, enhanced gastrointestinal reflux, diabetes
mellitus I or II, enhanced HbA1c levels, obesity, infection,
chronic obstructive pulmonary disease, renal disease, or
liver disease.
The first group of patients (group 1, n = 38) received
800 mL of carbohydrates 8 h before the procedure and
400 mL of carbohydrates 2 h before the procedure. The
second group of patients (group 2, n = 37) received 400
mL of carbohydrates 8 h before the procedure only. The
third group of patients (group 3, n = 38) received 400
mL of carbohydrates 2 h before the procedure only. The
fourth group of patients (group 4, control group, n = 39)
had an 8-h preoperative fasting period. The carbohydraterich drink that was used included 12.5 g/100 mL of
carbohydrates: 12% monosaccharides, 12% disaccharides,
76% polysaccharides, and 285 mOsm/kg of Nutricia
PreOp (Pfrimmer Nutricia GmbH, Germany).
Preanesthetic evaluations included a hemogram
(complete
blood
count),
coagulation
profile,
echocardiography, electrocardiogram, and coronary
angiography. A preoperative evaluation was performed
the night before the surgery. In the operating room, the
anesthesiologist applied an 18-gauge cannula via the
radial artery, and standard monitoring was used (5lead electrocardiogram and pulse oximetry). In all of
the groups, anesthesia was induced using 0.05 mg/kg
midazolam, 5 µg/kg fentanyl, 2 mg/kg propofol, and 0.6
mg/kg rocuronium. The patient was then intubated. After
intubation, a central venous catheter was placed in the
right internal jugular vein. Anesthesia was maintained
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with 2% sevoflurane, 2 µg/kg fentanyl, and 0.2 mg/kg of
rocuronium. The nasopharyngeal temperature and urine
output were monitored.
After performing a median sternotomy, a CPB was
instituted with 1500 mL of crystalloid priming volume and
mild hypothermia (28–32 °C). Systemic heparinization
was carried out before the CPB with unfractionated
heparin at an initial dose of 300 IU/kg. An activated
clotting time above 400 was targeted. The effect of the
heparin was reversed at the end of the CPB with 1–1.5
mg of protamine for every 100 IU of heparin. Myocardial
protection was achieved with cold blood cardioplegia at
20 °C during the CPB. Homologous donor packed red
blood cells were transfused if the hemoglobin fell below 6
g/dL. If the patient required inotropic and/or vasopressor
treatment, it was prospectively defined as 5–10 µg/kg
dobutamine and epinephrine (inotropic) and/or >10 µg/
kg dobutamine and norepinephrine (vasopressor).
2.1. Primary endpoints
The insulin requirement was chosen deliberately as a
surrogate marker to estimate the peripheral insulin
resistance (13). A blood glucose level of lower than 180
mg/dL was expected. If necessary, bolus insulin injections
were used: 5 IU of insulin for a blood glucose level of 200–
250 mg/dL, 8 IU for a level of 300–350 mg/dL, 12 IU for a
level of 350–400 mg/dL, and 20 IU for a level of 400–450
mg/dL.
2.2. Secondary endpoints
The inotropic and vasopressor requirements, ventilation
time, and ICU stay time were recorded for all of the
groups. Patient wellbeing, mouth dryness, hunger, anxiety,
and nausea were assessed using visual analog scale (VAS)
scores of 1–10. For all of the patients, the data were
recorded at T0 (preoperative), T1 (preoperative, after
inductions), T2 (postoperative, transferred to the ICU), T3
(6 h in the ICU), and T4 (postoperative first day).
2.3. Statistical analysis
The collected data were coded and statistically analyzed
using SPSS 15.0 (SPSS Inc., Chicago, IL, USA). Descriptive
statistics were determined for the numerical parametric
data as the mean ± standard deviation (SD), and for
the categorical data as the number and percentage. For
statistical testing, we used one-way analysis of variance and
the Tukey honestly significant difference test for multiple
comparisons of the parametric data. The differences were
considered to be significant for values of P < 0.05.
3. Results
The demographic characteristics exhibited no significant
differences among the study groups (Table 1). In addition,
there were no significant differences among the study
groups with regard to the operative characteristics (Table
2).

ŞAVLUK et al. / Turk J Med Sci
Table 1. Demographic characteristics.
Group 1

Group 2

Group 3

Group 4

P

Age (years)

59 ± 11

58 ± 11

57 ± 10

57 ± 12

0.32

Sex (male), %

84.2

81

82

82

0.41

Weight (kg)

80 ± 12

77 ± 10

72 ± 4

80 ± 11

0.26

Height (cm)

164 ± 10

165 ± 8

165 ± 10

169 ± 8

0.34

BMI (kg/m )

28 ± 3

29 ± 3

28 ± 2

28 ± 3

0.45

EF %

50 ± 7.7

50 ± 11

35 ± 7

47 ± 8.7

0.61

EuroSCORE

2.1 ± 1.3

2.6 ± 1.5

2.1 ± 1.5

2.6 ± 1.1

0.32

SA

2.5 ± 0.7

2.9 ± 0.7

3.5 ± 0.7

2.6 ± 0.6

0.34

Group 1

Group 2

Group 3

Group 4

P

Operation time (min)

208 ± 97

211 ± 60.2

194 ± 37.3

232 ± 77.3

0.08

CPB time (min)

88.8 ± 45.3

91 ± 26

87 ± 25

92 ± 32

0.07

ACC time (min)

49.3 ± 15.5

52 ± 19.1

49.9 ± 12.9

59 ± 25

0.06

2

Table 2. Operation characteristics.

The incidence of postoperative bleeding, any cardiac
arrhythmias, inotropic and vasopressor requirements, the
ventilation time, and the ICU stay time were evaluated
(Table 3). It was determined that the inotropic requirements
were significantly higher in the control group than in the
other groups (P = 0.04), but the vasopressor requirements
showed no significant differences among the groups. The
ventilation time was not significantly different among the
groups, but the ICU stay time was significantly longer in
the control group than in the other groups (P = 0.03).
The results of the VAS score comparisons for the 4
parameters (mouth dryness, hunger, nausea, and anxiety)
showed that nausea and anxiety were not significantly
different among the groups, while mouth dryness and

hunger were significantly higher in the control group than
in the other groups (P = 0.03 and P = 0.02, respectively)
(Figures 1 and 2). The increase in blood glucose level was
significantly higher in the control group when compared
to the other groups (P = 0.04) (Figure 3). The exogenous
insulin requirement was significantly higher in the control
group than in the other groups (P = 0.04) (Figure 4).
4. Discussion
In this prospective randomized clinical trial, those patients
who received preoperative carbohydrate-rich fluids had a
significantly reduced need for insulin. The carbohydrate
treatment helped to maintain normoglycemia, reduce the
length of the ICU stay, and reduce inotropic requirements.

Table 3. Postoperative characteristics.
Group 1

Group 2

Group 3

Group 4

P

Postoperative bleeding (mL)

837 ± 501

920 ± 625

900 ± 524

785 ± 435

0.5

Cardiac arrhythmia, %

31.6

24.3

47.4

38.5

0.7

Inotropic requirements, %

63.2

73

68.4

84.6

0.04

Vasopressor requirements, %

68.4

75.7

86.8

69.2

0.06

Ventilation time (h)

11.9 ± 4.5

13.2 ± 4.3

11.8 ± 4.1

14.5 ± 18.5

0.07

ICU stay time (days)

2.3 ± 0.6

3 ± 1.6

2.63 ± 3.35

4.6 ± 4.5

0.03
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Figure 1. Evaluation of mouth dryness with a VAS.
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Figure 2. Evaluation of hunger with a VAS.
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Figure 3. Evaluation of blood glucose levels among groups.

Figure 4. Evaluation of exogenous insulin requirements.

The need for insulin treatment in the nondiabetic CABG
patients indicated increased insulin resistance. The VAS
scores for mouth dryness and hunger were significantly
reduced when compared to those patients undergoing
preoperative fasting.
Surgical trauma produces a neuroendocrine response
mediated by the release of proinflammatory cytokines and
hormones (14). High concentrations of proinflammatory
cytokines have been associated with hyperglycemia
and insulin resistance under numerous physiological
conditions (15). Low-grade inflammation associated
with insulin resistance might be accentuated during
surgery; in particular, patients undergoing cardiac surgery
can experience aggravated inflammation and insulin

resistance, which contributes to worsening endothelial
dysfunction and glycemic control and an increased risk
of postoperative adverse outcomes (16,17). Surgical time
is directly proportional to the stress response; therefore,
during open-heart surgery, which is classified as a major
surgery, extracorporeal circulation and long duration
of surgery cause a greater stress response. However, the
effects of a preoperative oral carbohydrate treatment
may not be strong enough to counteract the effects of
the release of surgical trauma-related stress hormones
in cardiac surgery (18). The preoperative intake of oral
carbohydrates is related to a reduction in the inflammatory
response to surgical stress, because insulin-stimulated
glycogen synthase activity is attenuated by surgery, and
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glycogen stores in the liver, skeletal muscle, and adipose
tissue decrease (19). The metabolic stress variables that are
known to influence insulin resistance include the duration
of surgery (9) and use of vasoactive medication (4), which
did not differ significantly among the groups.
We assumed that any clinically relevant reductions
in insulin resistance would be identifiable by decreased
insulin requirements for maintaining comparable
blood glucose levels. In our study, the oral carbohydrate
treatments caused a significant reduction in the insulin
requirements and therefore a reduction in insulin
resistance and reduced length of stay in the ICU. Moreover,
the need for inotropic support differed significantly among
the study groups, with the carbohydrate treatment groups
showing reduced inotropic support requirements (P =
0.04). ICU stay time may increase depending on increased
inotropic requirement. Based on these data, we confirmed
the results of Breuer et al. (20) with regard to the possible
cardioprotective effects of a preoperative carbohydrate
drink. In other studies, the preoperative IV administration
of carbohydrates before cardiac surgery led to markedly
improved cardiac performance (12,21). Additionally, Lazar
et al. reported reduced inotropic scores postoperatively
after the perioperative administration of glucose-insulinpotassium to patients undergoing urgent CABG surgery
(12). During ischemia, the accumulation of free fatty
acid end products may impair ventricular arrhythmia by
increasing the level of oxygen-derived free radicals (22).
Glucose esterifies intracellular free fatty acids by increasing
the supply of alpha-glycerophosphate, thereby decreasing
the toxic metabolic end products of free fatty acids
including oxygen-derived free radicals (22,23). However,
some studies including patients undergoing major
abdominal or cardiac surgery (18) did not show improved
clinical outcomes with preoperative carbohydrate intake.

In our study, the preoperative intake of carbohydrates
resulted in improved postoperative recovery. For example,
in the carbohydrate treatment groups, the time in the ICU
was shorter than in the control group (P = 0.03). Although
the mechanical ventilation times in the ICU were not
statistically significant, the times in the carbohydrate
groups were shorter than in the control group (P = 0.07).
A subjective VAS was used to assess each patient’s
comfort using the following variables: nausea, anxiety,
mouth dryness, and hunger. The carbohydrate preparation
led to significant reductions in mouth dryness and
hunger (P = 0.03 and P = 0.02, respectively), but the
improvements in nausea and anxiety were similar for the
fasting group and carbohydrate groups. Hausel et al. (24)
used a VAS for a large sample size of ASA I–II patients
undergoing abdominal surgery and found no difference in
the thirst after the morning drink among the groups. In
addition, Helminen et al. (25) used a VAS for abdominal
surgery patients and found reduced thirst and hunger in
the treatment groups. In contrast, Henriksen et al. (26)
showed no differences between their study groups with
regard to thirst, hunger, anxiety, wellbeing, fatigue, pain,
and nausea. However, in that study, the patients given
carbohydrates reported significantly decreased hunger
and mouth dryness.
In conclusion, in this research we have provided
evidence of the safety of an oral carbohydrate drink
ingested before the induction of anesthesia for CABG
surgery. Moreover, the administration of carbohydrates
before elective cardiac surgery reduced insulin resistance.
Based on the VAS scores, the intake of carbohydrates
reduced mouth dryness and hunger. Overall, our data
show that preoperative oral carbohydrate treatments can
improve the postoperative outcomes of CABG surgeries,
but further research is necessary to confirm our results.

References
1.

Wolf AR. Effect of regional analgesia on stress responses to
pediatric surgery. Pediatr Anaesth 2012; 22: 19-24.

2.

Ljungqvist O, Soreide E. Preoperative fasting. Br J Surg 2003;
90: 400-406.

3.

Tsubo T, Kudo T, Matsuki A, Oyama T. Decreased glucose
utilisation during prolonged anaesthesia and surgery. Can J
Anaesth 1990; 37: 645-649.

4.

Mizock BA. Blood glucose management during critical illness.
Rev Endocr Metab Disord 2003; 4: 187-194.

5.

Jakob SM, Ensinger H, Takala J. Metabolic changes after cardiac
surgery. Curr Opin Clin Nutr Metab Care 2001; 4: 149-155.

6.

Lazar HJ, Philippides G, Fitzgerald C, Lancaster D, Shemin
RJ, Apstein C. Glucose-insulin-potassium solutions enhance
recovery after urgent coronary artery bypass grafting. J Thorac
Cardiovasc Surg 1997; 113: 354-362.

7.

Lolley DM, Myers WO, Ray JF, Sautter RD, Tewksbury DA.
Clinical experience with preoperative myocardial nutrition
management. J Cardiovasc Surg 1985; 26: 236-243.

8.

Nygren J, Thorell A, Jacobsson H, Larsson S, Schnell PO,
Hylen L, Ljungqvist O. Preoperative gastric emptying: effect of
anxiety and oral carbohydrate administration. Ann Sur 1995;
222: 728-734.

9.

Nygren J, Soop M, Thorell A, Efendic S, Nair KS, Ljungqvist
O. Preoperative oral carbohydrate administration reduces
postoperative insulin resistance. Clin Nutr 1998; 17: 65-71.

10.

Hausel J, Nygren J, Lagerkranser M, Hellstrom PM,
Hammarqvist F, Almstrom C, Lindh A, Thorell A, Ljungqvist
O. A carbohydrate-rich drink reduces preoperative discomfort
in elective surgery patients. Anesth-Analg 2001; 93: 1344-1350.

1685

ŞAVLUK et al. / Turk J Med Sci
11.

Noblett SE, Watson DS, Huong H, Davison B, Hainsworth
PJ, Horgan AF. Preoperative oral carbohydrate loading in
colorectal surgery: a randomized controlled trial. Colorectal
Dis 2006; 8: 563-569.

12.

Mathur S, Plank LD, McCall JL, Shapkov P, McIlroy K,
Gillanders LK, Merrie AE, Torrie JJ, Pugh F, Koea JB et al.
Randomized controlled trial of preoperative oral carbohydrate
treatment in major abdominal surgery. Br J Surg 2010; 97: 485494.

13.

Gungor N, Saad R, Janosky J, Arslanian S. Validation of
surrogate estimates of insulin sensitivity and insulin secretion
in children and adolescents. J Pediatr 2004; 144: 47-55.

14.

Nygren J. The metabolic effects of fasting and surgery. Best
Pract Res Clin Anaesthesiol 2006; 20: 429-438.

15.

Floh AA, Manlhiot C, Redington AN, McCrindle BW, Clarizia
NA, Caldarone CA, Schwartz SM. Insulin resistance and
inflammation are a cause of hyperglycemia after pediatric
cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg
2015; 150: 505-506.

16.

Farrer M, Fulcher G, Albers CJ, Neil HA, Adams PC, Alberti
KG. Patients undergoing coronary artery bypass graft surgery
are at high risk of impaired glucose tolerance and diabetes
mellitus during the first postoperative year. Metabolism 1995;
44: 1016-1027.

17.

Rapp-Kesek D, Stridsberg M, Andersson LG, Berne C,
Karlsson T. Insulin resistance after cardiopulmonary bypass in
the elderly patient. Scand Cardiovasc J 2007; 41: 102-108.

18.

Jarvela K, Maaranen P, Sisto T. Preoperative oral carbohydrate
treatment before coronary artery bypass surgery. Acta
Anaesthesiol Scand 2008; 52: 793-797.

1686

19.

Nygren J, Thorell A, Ljungqvist O. Preoperative oral
carbohydrate therapy. Curr Opin Anaesthesiol 2015; 28: 364369.

20.

Breuer JP, Von Dossow V, Von Heymann C. Preoperative
oral carbohydrate administration to ASA III-IV patients
undergoing elective cardiac surgery. Anaesth Analg 2006; 103:
1099-1108.

21.

Oldfield GS, Commerfold PJ, Opie LH. Effect of preoperative
glucose-insulin-potassium on myocardial glycogen levels
and on complications of mitral valve replacement. J Thorac
Cardiovasc Surg 1986; 91: 874-878.

22.

Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield
LJ. Glucose-insulin-potassium protection during the course of
hypothermic global ischemia and reperfusion: a new proposed
mechanism by the scavenging of free radicals. J Cardiovasc
Pharmacol 1983; 5: 35-43.

23.

Leidtke AJ. Lipid burden in ischemic myocardium. J Moll Cell
Cardiol 1988; 20: 65-74.

24.

Hausel J, Nygren J, Thorell A, Lagerkranser M, Ljungqvist O.
Randomized clinical trial of the effects of oral preoperative
carbohydrates on postoperative nausea and vomiting after
laparoscopic cholecystectomy. Br J Surg 2005; 92: 415-421.

25.

Helminen H, Vitanen H, Sajanti J. Effect of preoperative
intravenous carbohydrate loading on preoperative discomfort
in elective surgery patients. Eur J Anaesthesiol 2009; 26: 123127.

26.

Henriksen MG, Hessov I, Dela F. Effect of preoperative oral
carbohydrate and peptides on postoperative endocrine
response, mobilization, nutrition and muscle function in
abdominal surgery. Acta Anaesthesiol Scand 2003; 47: 191199.

